Department of Pharmaceutical Management and PharmacoEconomics, Hanoi University of Pharmacy, Hanoi, Viet Nam
Department of Pharmaceutical Management and PharmacoEconomics, Hanoi University of Pharmacy, Hanoi, Viet Nam.
BMJ Open. 2021 Aug 3;11(8):e051465. doi: 10.1136/bmjopen-2021-051465.
To identify the availability, prices and affordability of essential medicines for children (cEMs) in Hanam province, Vietnam.
Cross-sectional study.
One city and five districts of Hanam province.
66 public health facilities and 66 private drugstores.
The standardised methodology of the WHO and Health Action International was used to investigate 30 paediatric essential medicines. For each medicine, data were collected for two products: the lowest-priced medicine (LPM) and the highest-priced medicine (HPM). The availability of medicine was computed as the percentage of facilities in which this medicine was found on the day of data collection. Median prices of individual medicines were reported in local currency. Affordability was calculated as the number of days' wages required for the lowest-paid unskilled government worker to purchase standard treatments for common diseases. Data were analysed using R software V.4.1.0.
The mean availability of LPMs in the private sector (33.2%, SD=38.0%) was higher than that in the public sector (24.9%, SD=39.4%) (p<0.05). The mean availability of HPMs was extremely low in both sectors (11.3% and 5.8%, respectively). The mean availability of cEMs in urban areas was significantly higher than that in rural areas (36.5% and 31.6%, respectively, p<0.05). In the public sector, the prices of LPMs were nearly equal to the international reference prices (IRPs). In the private sector, LPMs were generally sold at 4.06 times their IRPs. However, in both sectors, the affordability of LPMs was reasonable for most conditions as standard treatments only cost a day's wage or less.
The low availability was the main reason hindering access to cEMs in Hanam, especially in the countryside. A national study on cEMs should be conducted, and some practical policies should be promulgated to enhance access to cEMs.
确定越南河静省儿童基本药物(cEMs)的可及性、价格和可负担性。
横断面研究。
河静省一个城市和五个区。
66 家公共卫生机构和 66 家私营药店。
采用世界卫生组织和国际健康行动的标准化方法,对 30 种儿科基本药物进行了调查。对于每种药物,收集了两种产品的数据:最便宜的药物(LPM)和最贵的药物(HPM)。药物的可及性计算为在数据收集当天发现该药物的设施百分比。以当地货币报告个别药物的中位数价格。可负担性计算为最低工资的非熟练政府工人购买常见疾病标准治疗所需的天数工资。使用 R 软件 V.4.1.0 分析数据。
私营部门 LPM 的平均可用性(33.2%,SD=38.0%)高于公共部门(24.9%,SD=39.4%)(p<0.05)。两个部门 HPM 的平均可用性都极低(分别为 11.3%和 5.8%)。城市地区 cEMs 的平均可用性明显高于农村地区(分别为 36.5%和 31.6%,p<0.05)。在公共部门,LPM 的价格接近国际参考价格(IRP)。在私营部门,LPM 的价格通常是其 IRP 的 4.06 倍。然而,在两个部门,作为标准治疗的 LPM 的可负担性对于大多数情况都是合理的,因为标准治疗只需要一天的工资或更少。
低可及性是阻碍河静省获得 cEMs 的主要原因,尤其是在农村地区。应该进行全国性的 cEMs 研究,并颁布一些切实可行的政策,以增加获得 cEMs 的机会。